Salazar, J.; Arranz, M.J.; Martin-Broto, J.; Serra, M.; Palmerini, E.; MartÃnez-GarcÃa, J.; Juan-Ribelles, A.; Andion, M.; Martinez-Trufero, J.; Gutiérrez, G.;
et al. VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol. Pharmaceuticals 2025, 18, 1855.
https://doi.org/10.3390/ph18121855
AMA Style
Salazar J, Arranz MJ, Martin-Broto J, Serra M, Palmerini E, MartÃnez-GarcÃa J, Juan-Ribelles A, Andion M, Martinez-Trufero J, Gutiérrez G,
et al. VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol. Pharmaceuticals. 2025; 18(12):1855.
https://doi.org/10.3390/ph18121855
Chicago/Turabian Style
Salazar, Juliana, MarÃa J. Arranz, Javier Martin-Broto, Massimo Serra, Emanuela Palmerini, Jeronimo MartÃnez-GarcÃa, Antonio Juan-Ribelles, Maitane Andion, Javier Martinez-Trufero, Guiomar Gutiérrez,
and et al. 2025. "VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol" Pharmaceuticals 18, no. 12: 1855.
https://doi.org/10.3390/ph18121855
APA Style
Salazar, J., Arranz, M. J., Martin-Broto, J., Serra, M., Palmerini, E., MartÃnez-GarcÃa, J., Juan-Ribelles, A., Andion, M., Martinez-Trufero, J., Gutiérrez, G., Echebarria-Barona, A., Vaz-Salgado, M. A., Regueiro, A., Alvarez, R., Valverde, C., Luna, P., Blay, P., & Sebio, A.
(2025). VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol. Pharmaceuticals, 18(12), 1855.
https://doi.org/10.3390/ph18121855
